logo
How to talk about mental health at work in Japan

How to talk about mental health at work in Japan

Japan Today29-05-2025
By Kerri King
Japan has long held a cultural ideal of 'enduring hardship' (我慢, gaman), especially in the workplace. This often means pushing through stress, exhaustion or emotional pain rather than speaking up. While mental health is still widely considered a private matter in Japan, that doesn't mean you have to struggle alone.
If you're feeling overwhelmed, anxious or depressed, support is available. And while Japan's workplace culture is still catching up, awareness around mental health is growing. Here's how to speak up, stay culturally aware, and protect your well-being in the process.
Cultural Barriers (But Change Is Starting)
Know the Signs Before It's Too Late
How to Talk About It (Japanese Work Culture Version)
Know Your Rights (Even if They're Hard to Use)
You Can Speak With the Company Doctor
A Disability Certificate May Help
If Work Isn't Safe, Get Outside Help
Therapy & Counseling (English-Speaking)
Legal & Employment Advice
You're Not Overreacting—You're Protecting Yourself
Cultural Barriers (But Change Is Starting)
Opening up about depression, anxiety or burnout in Japan can feel like admitting failure — a taboo in a collectivist culture where group harmony often outweighs individual needs. Though attitudes are shifting, mental illness has long been viewed through a lens of spiritual imbalance or personal weakness.
A 2022 survey by the Japan Productivity Center found only 15.3% of workers had received mental health support at work, despite nearly 60% reporting high levels of stress. Government reforms are encouraging better work-life balance, and some companies now offer occupational health services or counseling. Still, access remains uneven, and many employees hesitate to seek help.
By 2024, nearly half of full-time workers in Japan reported 'quiet quitting' — doing only the minimum required —underscoring just how widespread burnout has become.
Know the Signs Before It's Too Late
Don't let work take priority over your mental health.
Common Signs of Burnout
Crying quietly between meetings or after work
Chronic headaches, nausea, or other unexplained physical symptoms
Difficulty falling asleep, or waking up already tired
Trouble focusing, forgetfulness, or missing deadlines
A sense of emotional numbness or disconnection from your work
Social isolation can make this worse. Some people experience panic attacks on crowded morning trains—a symptom so common it's often overlooked.
Speaking up early, taking a break or seeking outside help is not a weakness. It's a form of self-leadership—and it might be the smartest move you make in your career.
How to Talk About It (Japanese Work Culture Version)
Talking about mental health at work is never easy, and in Japan, it often requires a careful balance of honesty, discretion and cultural sensitivity. The workplace tends to prize harmony, hierarchy and emotional restraint.
Start with Physical Language First
In many Japanese workplaces, it's more acceptable to frame emotional or mental distress as a physical issue. This isn't dishonest — it's a culturally appropriate way to open the door to support.
Phrases that work well include:
I'm not feeling well (体調が悪いです, taicho ga warui desu)
I'm going to the clinic regularly (通院しています, tsuin shiteimasu)
I need a short period of rest (少し休養が必要です, sukoshi kyuyo ga hitsuyō desu)
If You Mention Mental Health, Keep It Neutral
Should you choose to be more specific, avoid emotionally charged language unless you're speaking to someone trained in mental health or someone you trust deeply.
Try:
I'm receiving treatment for mental health reasons (メンタルヘルスのことで通院しています, mentaru herusu no koto de tsuin shiteimasu)
I'm receiving support from a professional (専門家のサポートを受けています, senmonka no sapoto o uketeimasu)
I'm experiencing some stress (少しストレスが溜まっています, sukoshi sutoresu ga tamatteimasu)
Know Your Rights (Even if They're Hard to Use)
Click here to read more.
External Link
https://gaijinpot.com/
© GaijinPot
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Study finds 213 deaths in Tokyo apparently caused by improper A/C use
Study finds 213 deaths in Tokyo apparently caused by improper A/C use

The Mainichi

time3 minutes ago

  • The Mainichi

Study finds 213 deaths in Tokyo apparently caused by improper A/C use

TOKYO -- There were 213 cases of deaths in the Japanese capital's 23 wards that were believed to have been caused by the improper use of air conditioners, according to joint research by the University of Tokyo Graduate School of Medicine and the Tokyo Metropolitan Medical Examiner's Office. Around 80% of these cases involved people living alone or elderly households. Some deaths are reportedly believed to have been caused by the air conditioner being set to "heating" instead of "cooling," or the remote control running out of batteries. The interim report of the collaborative study on heatstroke examined 1,447 cases between January 2013 and September 2023 in which heat or related factors were suspected to have contributed to the cause of death. According to the report, the deaths were concentrated between June and August. There were 30 to 35 such cases in 2016 and 2017, but that number rose to 250 in 2020 and 258 in 2022. A researcher said the figure "reflects the recent rise in temperatures, and the number of deaths has remained high." Air conditioners were turned off in more than 40% of the 1,295 cases that occurred indoors, excluding cases in which people passed away in saunas or during work. Some deaths were also caused by machine failure and malfunctions, including cases where the air conditioners were running but had been set incorrectly, or were clogged with dust which prevented airflow. The report recommends preventive measures such as replacing remote control batteries in advance and cleaning air conditioner filters. It also urges people to visit any elderly family members living alone to ensure their air conditioners are functioning properly.

New Pharmaceuticals Overseas: Change Situation in Which Foreign Drugs are Not Available in Japan
New Pharmaceuticals Overseas: Change Situation in Which Foreign Drugs are Not Available in Japan

Yomiuri Shimbun

time33 minutes ago

  • Yomiuri Shimbun

New Pharmaceuticals Overseas: Change Situation in Which Foreign Drugs are Not Available in Japan

If groundbreaking new drugs are available overseas but cannot be used in Japan, it puts many patients at a disadvantage. This situation must be changed immediately. Cases referred to as 'drug loss,' in which pharmaceuticals newly approved in other countries do not become available in Japan, are increasing. For some time now, new drugs developed by overseas pharmaceutical companies have tended to face delays in being introduced to Japan, due to this country's complicated application procedures for approval and additional clinical trials targeting Japanese patients. This problem has been dubbed 'drug lag.' The government's efforts to proceed with measures, such as strengthening the review system, have reduced delays. Instead of drug lag, however, there is now an increase in cases of drug loss. This is because more overseas companies have not even applied for approval of their products in Japan in recent years, making the situation even more serious. Behind this lies a drastic change in development methods for pharmaceuticals. Advances in life sciences have led to the production of complex biopharmaceuticals using genes and cells, shifting the primary developers from major pharmaceutical manufacturers to emerging companies. Many of them are small businesses, so they are not adequately established to expand globally. Furthermore, in Japan, there is a strong tendency to lower the prices of drugs to curb medical expenses. This may lead many overseas drugmakers to make a business decision that there is little advantage to paying the high costs required to enter the Japanese market. Traditionally, drug loss has been conspicuous for rare ailments and pediatric diseases. However, now that the problem will likely expand to more common diseases such as breast cancer and diabetes, it is feared that patients in Japan will be unable to widely benefit from new drugs that are available overseas. To bring drugs developed overseas to Japan, it is necessary to provide more information to drugmakers and lower hurdles to applying for approval in Japan. To support U.S. companies in their applications, the Health, Labor and Welfare Ministry has established an office in the United States to assist them with the review process. It is also essential to establish a system that maintains prices that reflect the value of new pharmaceuticals. In addition to attracting overseas makers, this would also promote technological innovation in the pharmaceutical industry as a whole. However, public health cannot be steadily protected in Japan through an approach that relies on overseas companies. It is necessary to increase the number of new drugs originating in Japan. Japan's research capabilities are not low, but universities and other institutions find it difficult to directly link their research results to businesses, and this environment is hindering the improvement of pharmaceutical development capabilities. In the United States, many universities, startups and investors are concentrated in Boston to work together to produce a steady stream of new drugs. In Japan as well, it is important to create a similar hub, described as an ecosystem, for advanced academic-industrial collaboration. (From The Yomiuri Shimbun, July 28, 2025)

Japanese women top global life expectancy for 40th straight year
Japanese women top global life expectancy for 40th straight year

Japan Today

time2 days ago

  • Japan Today

Japanese women top global life expectancy for 40th straight year

Japanese women had the highest life expectancy in the world in 2024, marking the 40th consecutive year at the top, government data showed Friday. Their average life expectancy was 87.13 years, a slight drop of 0.01 year from 2023. Men's life expectancy remained unchanged at 81.09, but their global ranking slipped to sixth from fifth, the Ministry of Health, Labor and Welfare said. Japan was followed in the global ranking for women by South Korea at 86.40 and Spain at 86.34. Among men, Sweden ranked first at 82.29, followed by Switzerland at 82.20 and Norway at 81.59, the ministry said. Life expectancy for both men and women declined in 2021 and 2022, due largely to the impact of the COVID-19 pandemic, but rebounded in 2023. © KYODO

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store